Nevertheless, some non-specific diagnostic markers, such as complete blood count (CBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP), are commonly employed in clinical practice to monitor the growth and progression of hematological neoplasms [13]. This evidence concerns the gene CRP and hematopoietic and lymphoid system neoplasm.